Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecapegfilgrastim for chemotherapy-induced neutropenia in lymphoma
NCT04460508Phase 2Unknown
- Sponsor
- The First Hospital of Jilin University
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of mecapegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by The First Hospital of Jilin University. Status: unknown.
02
Drugs
mecapegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT04460508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04460508.